This product is a recombinant monoclonal antibody, which offers several advantages including:
  - - High batch-to-batch consistency and reproducibility
  - - Improved sensitivity and specificity
  - - Long-term security of supply
  - - Animal-free production
  
 General notes
 Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.